3-Week Study of Asenapine, Olanzapine and Placebo for Treatment of Bipolar Mania (A7501005)(COMPLETED)

This study has been completed.
Sponsor:
Collaborator:
Pfizer
Information provided by:
Organon
ClinicalTrials.gov Identifier:
NCT00159796
First received: September 8, 2005
Last updated: August 11, 2008
Last verified: August 2008